Global Biosimilars Market 2021-2025

Global Biosimilars Market 2021-2025

Technavio has been monitoring the biosimilars market and it is poised to grow by $ 31.40 bn during 2021-2025, progressing at a CAGR of 24.77% during the forecast period. Our report on the biosimilars market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by factors such as the price advantage of biosimilars over biologics and the patent expiry of major biologics. In addition, the price advantage of biosimilars over biologics is anticipated to boost the growth of the market as well.

The biosimilars market analysis includes the application segment and geographic landscape.

Technavio's biosimilars market is segmented as below:

By Application

  • Oncology and hematology
  • Immunology
  • Endocrinology
  • Nephrology
By Geography
  • Europe
  • Asia
  • North America
  • ROW
This study identifies the government initiatives to increase the use of biosimilar medicines as one of the prime reasons driving the biosimilars market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on biosimilars market covers the following areas:
  • Biosimilars market sizing
  • Biosimilars market forecast
  • Biosimilars market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biosimilars market vendors that include Amgen Inc., Biogen Inc., Boehringer Ingelheim International GmbH, Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Fresenius Kabi AG, Merck and Co. Inc., Novartis AG, Pfizer Inc., and Viatris Inc. Also, the biosimilars market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.


  • Executive Summary
  • Market Landscape
    • Market ecosystem
      • Parent market
        • Table Parent market
        • Table Market characteristics
    • Value chain analysis
      • Table Value chain analysis for pharmaceuticals
      • Research and development (R&D) and drug discovery
      • Integration and product development
      • Manufacturing
      • Outbound logistics
      • Marketing and sales
      • Support services
      • Innovation
  • Market Sizing
    • Market definition
      • Table Offerings of vendors included in the market definition
    • Market segment analysis
      • Table Market segments
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
      • Table Global - Market size and forecast 2020 - 2025 ($ billion)
      • Table Global market: Year-over-year growth 2020 - 2025 (%)
  • Five Forces Analysis
    • Five forces summary
      • Table Five forces analysis 2020 & 2025
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2020
  • Market Segmentation by Application
    • Market segments
      • Table Application - Market share 2020-2025 (%)
    • Comparison by Application
      • Table Comparison by Application
    • Oncology and hematology - Market size and forecast 2020-2025
      • Table Oncology and hematology - Market size and forecast 2020-2025 ($ billion)
      • Table Oncology and hematology - Year-over-year growth 2020-2025 (%)
    • Immunology - Market size and forecast 2020-2025
      • Table Immunology - Market size and forecast 2020-2025 ($ billion)
      • Table Immunology - Year-over-year growth 2020-2025 (%)
    • Endocrinology - Market size and forecast 2020-2025
      • Table Endocrinology - Market size and forecast 2020-2025 ($ billion)
      • Table Endocrinology - Year-over-year growth 2020-2025 (%)
    • Nephrology - Market size and forecast 2020-2025
      • Table Nephrology - Market size and forecast 2020-2025 ($ billion)
      • Table Nephrology - Year-over-year growth 2020-2025 (%)
    • Market opportunity by Application
      • Table Market opportunity by Application
  • Customer landscape
    • Table Customer landscape
  • Geographic Landscape
    • Geographic segmentation
      • Table Market share by geography 2020-2025 (%)
    • Geographic comparison
      • Table Geographic comparison
    • Europe - Market size and forecast 2020-2025
      • Table Europe - Market size and forecast 2020-2025 ($ billion)
      • Table Europe - Year-over-year growth 2020-2025 (%)
    • Asia - Market size and forecast 2020-2025
      • Table Asia - Market size and forecast 2020-2025 ($ billion)
      • Table Asia - Year-over-year growth 2020-2025 (%)
    • North America - Market size and forecast 2020-2025
      • Table North America - Market size and forecast 2020-2025 ($ billion)
      • Table North America - Year-over-year growth 2020-2025 (%)
    • ROW - Market size and forecast 2020-2025
      • Table ROW - Market size and forecast 2020-2025 ($ billion)
      • Table ROW - Year-over-year growth 2020-2025 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity by geography
      • Table Market opportunity by geography ($ billion)
  • Drivers, Challenges, and Trends
    • Market drivers
      • Price advantage of biosimilars over biologics
      • Patent expiry of major biologics
      • Government initiatives to increase the use of biosimilar medicines
      • Faster approval process for biosimilars
    • Market challenges
      • Market access barriers for biosimilars
      • Supply chain challenges of biosimilars
      • Obstacles to reimbursement of biosimilars
      • Challenges in conducting robust preclinical bioequivalence and clinical safety studies
        • Table Impact of drivers and challenges
    • Market trends
      • Patients and physician's willingness to switch to biosimilars
      • Therapeutic interchangeability regulations for biosimilars across countries
      • Biosimilar "patent dance"
      • Many originator companies entering the biosimilar market
  • Vendor Landscape
    • Overview
    • Vendor landscape
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
      • Table Industry risks
  • Vendor Analysis
    • Vendors covered
      • Table Vendors covered
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Amgen Inc.
      • Table Amgen Inc. - Overview
      • Table Amgen Inc. - Business segments
      • Table Amgen Inc. – Key news
      • Table Amgen Inc. - Key offerings
    • Biogen Inc.
      • Table Biogen Inc. - Overview
      • Table Biogen Inc. - Business segments
      • Table Biogen Inc. – Key news
      • Table Biogen Inc. - Key offerings
    • Boehringer Ingelheim International GmbH
      • Table Boehringer Ingelheim International GmbH - Overview
      • Table Boehringer Ingelheim International GmbH - Business segments
      • Table Boehringer Ingelheim International GmbH - Key offerings
      • Table Boehringer Ingelheim International GmbH - Segment focus
    • Eli Lilly and Co.
      • Table Eli Lilly and Co. - Overview
      • Table Eli Lilly and Co. - Business segments
      • Table Eli Lilly and Co. – Key news
      • Table Eli Lilly and Co. - Key offerings
    • F. Hoffmann-La Roche Ltd.
      • Table F. Hoffmann-La Roche Ltd. - Overview
      • Table F. Hoffmann-La Roche Ltd. - Business segments
      • Table F. Hoffmann-La Roche Ltd. – Key news
      • Table F. Hoffmann-La Roche Ltd. - Key offerings
      • Table F. Hoffmann-La Roche Ltd. - Segment focus
    • Fresenius Kabi AG
      • Table Fresenius Kabi AG - Overview
      • Table Fresenius Kabi AG - Business segments
      • Table Fresenius Kabi AG - Key offerings
      • Table Fresenius Kabi AG - Segment focus
    • Merck and Co. Inc.
      • Table Merck and Co. Inc. - Overview
      • Table Merck and Co. Inc. - Business segments
      • Table Merck and Co. Inc. - Key offerings
      • Table Merck and Co. Inc. - Segment focus
    • Novartis AG
      • Table Novartis AG - Overview
      • Table Novartis AG - Business segments
      • Table Novartis AG – Key news
      • Table Novartis AG - Key offerings
      • Table Novartis AG - Segment focus
    • Pfizer Inc.
      • Table Pfizer Inc. - Overview
      • Table Pfizer Inc. - Business segments
      • Table Pfizer Inc. – Key news
      • Table Pfizer Inc. - Key offerings
    • Viatris Inc.
      • Table Viatris Inc. - Overview
      • Table Viatris Inc. - Business segments
      • Table Viatris Inc. – Key news
      • Table Viatris Inc. - Key offerings
      • Table Viatris Inc. - Segment focus
  • Appendix
    • Scope of the report
      • Market definition
      • Objectives
      • Notes and caveats
    • Currency conversion rates for US$
      • Table Currency conversion rates for US$
    • Research methodology
      • Table Research Methodology
      • Table Validation techniques employed for market sizing
      • Table Information sources
    • List of abbreviations
      • Table List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook